Baxter International Inc. (BAX)
NYSE: BAX · Real-Time Price · USD
30.43
-0.28 (-0.91%)
May 5, 2025, 4:00 PM EDT - Market closed
Baxter International Revenue
Baxter International had revenue of $2.63B in the quarter ending March 31, 2025, a decrease of -26.92%. This brings the company's revenue in the last twelve months to $10.77B, down -27.67% year-over-year. In the year 2024, Baxter International had annual revenue of $10.64B with 2.66% growth.
Revenue (ttm)
$10.77B
Revenue Growth
-27.67%
P/S Ratio
1.44
Revenue / Employee
$179,517
Employees
60,000
Market Cap
15.61B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 10.64B | 276.00M | 2.66% |
Dec 31, 2023 | 10.36B | 303.00M | 3.01% |
Dec 31, 2022 | 10.06B | -2.09B | -17.20% |
Dec 31, 2021 | 12.15B | 473.00M | 4.05% |
Dec 31, 2020 | 11.67B | 311.00M | 2.74% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Thermo Fisher Scientific | 42.90B |
BAX News
- 4 days ago - Baxter International Inc. (BAX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 days ago - Baxter Reports Strong Medical Devices Sales In Q1, Lifts 2025 Guidance, Stock Jumps - Benzinga
- 4 days ago - Baxter tops quarterly estimates on strong demand for medical devices - Reuters
- 4 days ago - Baxter Reports First-Quarter 2025 Results - Business Wire
- 6 days ago - Baxter to Present at Bank of America Securities 2025 Health Care Conference - Business Wire
- 25 days ago - Baxter Launches New Room Temperature Hemopatch Sealing Hemostat for Rapid and Convenient Application During Surgery - Business Wire
- 5 weeks ago - Baxter to Host Annual Meeting of Stockholders in Virtual Format - Business Wire
- 7 weeks ago - Stocks beating the stock market's recent Trump slump have this in common - Market Watch